BMGI was a knowledge partner to Pharma Spectrum 2014. The event was held on 20 Feb 2014, Holiday Inn, Mumbai, India. BMGI is a Pharmaceuticals Consulting Firm that provides not only strategic visions but also a practical and technical methodology to help companies deal with existing challenges.

1. BMGI was a knowledge partner to Pharma Spectrum 2014. The event was held on 20 Feb
2014, Holiday Inn, Mumbai, India. BMGI’s expert knowledge in Pharmaceuticals Consulting,
provides not only strategic visions but also a practical and technical methodology to help
companies deal with existing challenges.
Source: http://www.goldmancommunications.com/t4_type1_EventsMainPast.php?eventid=25

2. Goldman Communications
Goldman Communications has planned a Pharma
Spectrum 2014, which is India’s flagship event to cover a
range of challenges & opportunities in the Indian Pharma
space be it Manufacturing, Operational Excellence, Drug
Delivery System & Pharma Analytics. It is a convergence
of over 150 senior profiles to understand the latest
developments and the best practices that would reshape
this sector in the near future. This initiative is a unique
composition of 3 diverse & different conferences that
would address majority of concerns and the pave the
road ahead for a whole gamut of opportunities that this
industry would witness in the near future.

3. Pharma Manufacturing Excellence
 The future of pharmaceutical development and manufacturing
 Effective strategies and planning for expanding production at the facilities
 Encashing on continuous manufacturing
 Laying the foundation for Global Operational Excellence Initiative
 Gen-Next in Operational Excellence
 Surviving inspections in today’s global regulatory environment
 Protecting your product by maintaining effective Contract Manufacturing
Organizations relationships
 Charting the course for the post generic manufacturing era
 Protecting the integrity of shipments in storage and transit

4. Innovations in Drug Delivery System
 Exploring & global comparison of latest Government regulatory guidelines for DDS in India
 Delivery of Biologics Panel: New Paradigms, Formulation Challenges, & Partnering Needs
 Emerging techniques and development trend of oral solid controlled-release dosage
 Nanomedicine: Why Should Pharma be Investing in this Area?
 Disrupting the Future of Healthcare with Drug Delivery
 Healthcare Mega Trends and the Role of Transdermal Drug Delivery in Meeting Evolving
Market Needs
 Latest Trends in Nasal Drug Delivery System
 Market trends on Pre filled syringe based auto Injectables

5. Advances in Pharma Analytics
 Establishing techniques for identification and characterization of impurities in API and understanding
effect of these impurities on the drug product
 Determining effective analytical techniques to achieve impurity control in formulated product.
 Panel Discussion: Updating on the increased regulatory requirements in analytical testing and
understanding query handling to achieve global regulatory compliance
 Understanding importance of particle size for both drug product and drug substance
 Developing an effective QbD approach for analytical method development to understand and overcome
application challenges in analytical testing.
 Navigating through effective implementation of ICP-MS and ICP-OES to achieve global regulatory
compliance specifically towards heavy metal analysis
 Updating about the advancement in LC-MS (Q-TOF)
 Learning innovative measures to overcome challenges around residual solvents by adopting effective
analytical methods
 Learning analytical techniques focussing on heavy metal analysis to comply with recent global
regulatory requirements and USP directives.